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Objective. Latino populations, particularly Mexican-Americans who comprise 65% of the Latinos in the U.S.,
are disproportionately affected by HPV-related diseases. The HPV vaccination completion rates remain low,
well below the Healthy People 2020 goal. In this study we assessed the effect of parental education and a text
messaging reminder service on HPV vaccine completion rates among eligible children of Mexican American
parents.
Study design. Nonequivalent group study of Mexican parents of HPV vaccine eligible children attended the
Health Window program at the Mexican Consulate in New York City, a non-clinical, trusted community setting,
during 2012–2013. 69 parents received HPV education onsite, 45 of whom also received a series of text message
vaccination reminders. We measured HPV vaccination completion of the youngest eligible children of Mexican
parents as the main outcome.
Results. 98% of those in the education plus text messaging group reported getting the ﬁrst dose of the vaccine
for their child and 87% among those in the educational group only (p= 0.11). 88% of those receiving the 1st
dose in the text messaging group reported completing the three doses versus 40% in the educational group
only (p = 0.004).
Conclusions. Parental text messaging plus education, implemented in a community based setting, was
strongly associated with vaccine completion rates among vaccine-eligible Mexican American children.
Although pilot in nature, the study achieved an 88% series completion rate in the children of those who
received the text messages, signiﬁcantly higher than current vaccination levels.© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Every year approximately 35,000 cases of Human Papilloma Virus
(HPV) associated cancers occur in the U.S., with greater incidence
among ethnic and racial minority populations (Jemal et al., 2013;
Human papillomavirus-associated cancers-United States, 2002–2008,
2012). Latino populations, particularly Mexican-Americans, who com-
prise 65% of the Latinos in the U.S. (33.5 million) (Pew Research
Hispanic Center, 2013), are disproportionally affected by HPV infection
and HPV-related diseases (Human papillomavirus-associated cancers—
United States, 2002–2008, 2012; Agency for Healthcare Research and
Quality, 2011; Kahn et al., 2007; Kepka et al., 2010). The HPV vaccine
has the potential to prevent the large majority of HPV associated cancer
cases (Koutsky et al., 2002). The vaccine is currently approved for malesBehavioral Sciences, Immigrant
ancer Center, 300 E. 66th Street
. This is an open access article underand females 9–26 years of age (U.S. Food andDrugAdministration, 2009),
with the greatest beneﬁts presumably achievedwhen administered at an
early age, prior to the start of sexual activity.
Despite the signiﬁcant advantages of preventing HPV infection,
uptake of the vaccine has been suboptimal. According to the 2012
National Immunization Survey-Teen (NIS-Teen), the initiation rate for
HPV vaccine series (ﬁrst dose) was 54% for females, with only 33%
completing three doses (among all adolescents) (Center for Disease
Control P, 2013). The rate for Latina girls was slightly higher for ﬁrst
dose uptake (56%) compared to non-Hispanic Whites (51%), but lower
for completion of the three doses (29% vs. 36%) (Jemal et al., 2013).
Moreover, HPV vaccination among males is even lower. Among Latino
boys 13–17 years of age, only 14.8% received the ﬁrst dose, while only
2.7% completed the three doses in 2011 (Centers or Disease Control
and Prevention, 2012). These rates are well below the Healthy People
2020 objective of an 80% completion rate (U.S. Department of Health
and Human Services, 2013).
The most universal HPV vaccine barriers cited by Latino parents are
lack of awareness about HPV and the HPV vaccine, and lack of providerthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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2009; Yeganeh et al., 2010). In addition, approximately 80% of Latino
children in theU.S. had health insurance in 2010 and almost 87% reported
having a regular source ofmedical care potentially reducing the barrier to
access care. Furthermore, the HPV vaccine for children can be obtained
through the Vaccines for Children Program at no cost. (Centers for
Disease Control and Prevention: Vaccines for Children Program (VFC),
2013) Other parental barriers to obtain the vaccine for their children
have been described in the literature, including parental distrust of the
vaccine and issues related to promiscuity although less prominent than
those described above (Lechuga et al., 2014).
Latino children are the fastest growing child population in the U.S.,
numbering 23.6 million in 2010 (Pew Research Hispanic Center, 2011;
Fry and Passel, 2009). Over 300,000 Mexicans live in New York City and
almost half are under the age of 18 years (United States Census Bureau,
2013). In 2007, the Consulate General of Mexico in New York established
a “Health Window” program to serve Mexicans attending the Consulate.
The “Health Window,” or “Ventanilla de Salud” in Spanish, is a bi-
national collaborative program. Academic and government institutions
work to increase access to health care, raise awareness around health
related issues, provide health screenings, and promote healthy lifestyle
choices among low-income and migrant Latino communities in the
United States. The unique structure of this model is the physical
presence of the program on consular premises, which is designed
to provide a diversity of services and resources in a culturally and
linguistically sensitive manner, in a trusted environment, with trusted
health personnel.
The Community Preventive Services Task Force (CSPTF) recommends
“increasing community demand,” deﬁned as “efforts to provide or
disseminate information, advice, or both to clients to increase and
improve their efforts to seek appropriate vaccination” (Community
Preventive Services Task Force) to increase vaccination rates. The
HPV vaccine presents a particularly difﬁcult additional barrier because
three doses are required to accomplish full immunization compared
to one dose for most other vaccines for older children and adults (i.e.
ﬂu vaccine). These additional 2 steps (second and third doses) have
undermined vaccination completion, reducing vaccination rates.
Kharbanda et al. investigated the use of textmessaging as a reminder
to complete the three doses of theHPV vaccine and found an increase of
15% of on-time receipt of the next HPV vaccine dose among parents
receiving a text message reminder for their child's vaccination, though
all participants included in that study had already initiated the vaccine
series (Kharbanda et al., 2011). Text messaging is widely used among
the general population in the U.S., including Latinos. According to
the Pew Research Center, over 85% of Americans own a cell phone
and almost 75% send and/or receive text messages; these rates
are similar for Hispanics and non-Hispanics (Pew Research Center,
2012).
In this pilot study, we assessed an intervention set in a non-clinical,
trusted community setting serving largeMexican American populations,
designed to increase HPV vaccine completion rates. The intervention
contained a culturally-tailored HPV education intervention for Mexican
parents of vaccine eligible children, followed, for a subset of parents by
text-messaging vaccination reminders. Vaccine series completion rates
were compared for the children of the two groups.Methods
We conducted an exploratory study using a nonequivalent group
design of Mexican parents of HPV vaccine eligible children, attending
the Health Window Program at the Mexican Consulate in New York
City, to assess the effect of parental HPV vaccine education with and
without text messaging reminders on vaccination completion (3 doses)
rates. This study was conducted under approval from the institutional
review board at Memorial Sloan-Kettering Cancer Center.Setting
The HealthWindow program at theMexican Consulate in New York
City is open weekdays and offers services described above to all those
attending the Consulate. The Health Window does not administer the
HPV vaccine or offers direct health care. The General Consulate of
Mexico in New York serves an average of 400 visitors every day and
an average of 90,000 people a year from the New York Metropolitan
area.
Study population
Between December 2012 and May 2013 all those who attended the
Health Window at the Consulate General of Mexico in New York City
were approached consecutively to assess their eligibility to the study
using a standardized intake form and to obtain consent to participate.
This population was a self-selected group that decided to attend the
HealthWindows at the consulate for other thanHPV vaccine information
purposes. The following were used as inclusion criteria: An 18 years
or older parent that: 1) was born in Mexico, or born in the U.S. but
self-describes as Mexican American, 2) Spanish is his or her primary
language, 3) has at minimum one child between the ages of 9 through
17 years who has not received the HPV vaccine, 4) self-identiﬁes as
the child's main caregiver, 5) currently owns a cell phone and uses
text messaging services. Parents that had multiple HPV vaccine eligible
children but one ormore had already received the vaccine (any number
of doses)were excluded from the study. It is important to note that to the
best of our knowledge, there were no changes to the HPV guidelines,
policies or payment during the course of the study in the New York City
metropolitan area.
Intervention
Parental education. Trained lay health workers at the Health Window
provided a one on one educational session to all study participants.
The session included information on HPV, the HPV vaccine, and
HPV-related cancers, and answered any questions the parent might
have. A publicly available brochure obtained at the Centers for Disease
Control and Prevention website about HPV vaccine was given to the
parents (available at: http://www.cdc.gov/std/hpv/common/), and
assistance linking their child with health care services was offered if
needed. Parents were encouraged at the end of the session, to make
an appointment with their child's provider or go to an immunization
clinic to receive the vaccine. On average the educational session lasted
20 min.
Text messaging. After 24 consecutive participants were recruited to the
non text messaging arm of the study, the following 45 participants
were assigned to receive messages once a week reminding them of
their child's vaccination eligibility, starting approximately one week
after participating in the educational session. These reminders occurred
until uptake of the ﬁrst dose of the vaccine was reported, or for 6 weeks
after recruitment. The message sent included the following: “As a
reminder, your child is eligible for the HPV vaccine, don't wait, protect
your child!”. If a participant reported administering the ﬁrst vaccine
dose to his/her child (assessed by telephone), text messages resumed
weekly starting one month prior to the second dose due date or until
the second dose was reported or for a maximum of 8 weeks. The
message sent during this stage was “As a reminder, your child is eligible
for the second dose of the HPV vaccine.” and “Don't forget, your child is
not fully protected until he or she gets the three doses.”. Finally, a third
batch of weekly text message reminders started 1 month prior to the
due date of the third dose, depending on the time of second dose and
only if a second dose was reported, and continued for 8 weeks or until
the third dose was reported. The message sent at this stage was “As a
reminder, your child is eligible for the third and ﬁnal dose of the HPV
Table 1









Female 83% 78% 0.75
Age (mean) 34 37 0.08
Education level
0 to 5th grade 13% 5%
5th grade to 11th grade 58% 69%
Completed high school or above 29% 26% 0.55
Years in the US
Less than 5 years 71% 64%
5 or more years 29% 36% 0.59
English proﬁciency
Less than very well 88% 91%
Very well 12% 9% 0.58




4 0% 7% 0.26
Youngest vaccine eligible child
Son 42% 47%
Daughter 58% 53% 0.89
Youngest vaccine eligible child
Insured 92% 85% 0.48
Youngest vaccine eligible child
Has regular source of care 100% 98% 1.00
HPV vaccine awarenessa
Yes 29% 22% 0.51
a HPV vaccine awareness prior to participating in the study.
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gets the three doses.”. All messages were sent in Spanish.
Primary outcome and outcome evaluation
The primary outcome assessed was HPV vaccine series completion
(3 doses) for a parent's youngest eligible child (if more than one child
was eligible), self reported by the parent. Although outcomes among
siblings would be expected to correlate, we measured the youngest
child's vaccine status for two reasons: 1) the youngest child's vaccine
administration would most likely reﬂect parental decision-making
compared to an older sibling, and 2) the youngest child may beneﬁt
the most from this preventive measure.
All outcome data were collected by telephone. The ﬁrst outcome
evaluation call occurred 2 weeks after the educational session, when
participants were asked if and when their child obtained the vaccine.
If no vaccination was reported, additional outcomes assessment calls
were made at 4 and 6 weeks after the educational session. If the dose
was still not received by then, the participant was considered a ‘no
effect’ and no further follow-up was conducted. Calls were made only
to assess outcome; health counseling was not provided at these calls.
All participants who reported providing the ﬁrst dose of the HPV
vaccine to their youngest eligible child were followed by phone to
assess completion of the second dose approximately 2 months after
the ﬁrst dose, and, if a second dose was reported, approximately
6 months after initial dose to assess third dose completion.
Statistical analysis
Descriptive statistics were used on all study variables to assess the
distributions of the data and to compare the two independent groups.
Outcome analysis was performed utilizing the between group design,
where the independent variable was the group assignment (educational
session alone, vs. educational session plus text messaging reminders)
and the outcome (vaccination completion). We used chi-square or
Fisher's exact test for this analysis. In addition, logistic regression was
used to assess likelihood of vaccination completion when controlling
for participant's socio-demographic and other variables.
Results
Sixty-nine participants were recruited to the study. The ﬁrst 24
received the educational session alone and the following 45 received
the educational session followed by the text messaging reminder
system. Initially the study was designed to recruit 25 parents in each
arm, but the text messaging arm was extended to 45 subjects during
recruitment. There was an unexpectedly high interest in information
about theHPVvaccine and in participating in the study in this population
throughout the implementation of the study. In addition, there was a
high rate of participants meeting the inclusion criteria and the study
didn't have available resources to extend enrollment further.
One participant in the education session only group was lost to
follow-up, and two were lost in the educational session plus text
messaging group. These three participants did not answer any of the
calls from the study team; all other participants were successfully
reached by phone to assess outcomes. All participants were born in
Mexico, all reported Spanish as their primary language, 99% reported
having a primary source of care for their child at study enrollment,
and 87% reported having health insurance for their child. Demographics
and other characteristics of the sample are shown in Table 1 by group.
No statistically signiﬁcant socio-demographic differences were found
between groups.
Ninety-eight percent of those in the educational plus text messaging
group reported getting the ﬁrst dose of the vaccine for their youngest
eligible child and 87% in the educational group only (p = 0.11). The
remainder reported not providing the vaccine within 6 weeks after
the initial participation in the study and were not subsequently follow-
ed. Of those who received the ﬁrst dose, 88% in the text messaginggroup reported receipt by their child of the full three doses and 40% in
the education only group (p = 0.004). Of those that completed the
vaccination series, 45% in the text messaging group and 40% in the
education only group were boys (p = 0.56).
Because interest in the study was high and recruitment continued
past 25 for the group receiving text messaging, we compared the
vaccination rate for the ﬁrst 25 participants in this group versus the
rate among the group receiving parental education alone. The rate of
vaccination completion for theﬁrst 25 participants in the textmessaging
group was 82% among those that received the ﬁrst dose, compared to
40% among those in the education only group (p = 0.037).
Vaccination completion was associated with parents' age (38-year
old mean age among those that reported vaccinating their child vs.
34-year old mean age among those that did not, (p = 0.012)) and
with awareness of the vaccine before participating in the study (51%
were aware of the vaccine and reported vaccinating their child
vs 38% that were not aware and reported vaccinating their child
(p = 0.018)). No other variables, including parent's gender, years
in the U.S., parent's education level, parent's English proﬁciency,
total number of children eligible for the vaccine and gender of the
youngest vaccine eligible child, were signiﬁcantly associated with
vaccination series completion.
Using a binary logistic regression analysis to calculate likelihood of
vaccination in the entire sample, we found that those in the text
message groupwere 15.5 timesmore likely to complete the vaccination
(3 doses) than those in the education only group (p b 0.001). Other
variables although not found to be statistically signiﬁcantly associated
with the outcomewere included in the equation since, based on current
published evidence, they have the potential to modify the association
within the intervention and the outcome (Kessels et al., 2012; Reiter
et al., 2013; Allen et al., 2012). These variables included gender of
parent, gender of youngest HPV eligible child, age of parent, English
proﬁciency of parent and if parent had any knowledge about the HPV
vaccine prior to the study (none statistically signiﬁcant). Results are
shown in Table 2. The equation's overall success rate (or prediction of
Table 2
Binary logistic regression equation.
Predictor B Wald X2 p Exp(B)
Text/no text group 2.72 14.22 b .001 15.2
Parent's gender 1.25 2.28 0.13 3.50
Gender of youngest eligible child −0.06 0.009 0.92 0.93
Age of parent 0.10 2.62 0.10 1.11
English proﬁciency of parent 0.28 0.13 0.71 1.32
Parent's prior HPV vaccine knowledge −0.79 1.07 0.30 0.45
557A. Aragones et al. / Preventive Medicine Reports 2 (2015) 554–558vaccination completion) was 80%, with a sensitivity of prediction of
85.7% and a speciﬁcity of prediction of 73.3%.
Discussion
HPV-related cancers are highly preventable, yet are unnecessarily
rampant among Mexican immigrants and other minority populations.
Our study used an inexpensive, simple intervention, parental education
plus text messaging reminders, to increase vaccine initiation and
completion rates among vaccine-eligible Mexican American children.
As described in the literature, HPV vaccination rates have remained
low and are well below the Healthy People 2020 goal of 80% (Center
for Disease Control P, 2013; Centers or Disease Control and Prevention,
2012; U.S. Department of Health andHuman Services, 2013). Our study,
although of feasibility in nature, found an 84% series completion rate
for those receiving the text message reminders, a highly signiﬁcant
association between intervention and vaccination rate (P b 0.00) and
an increase from current vaccination levels.
Increasing rates of HPV vaccination in the U.S. has proven to be
difﬁcult, particularly among minority and high risk populations.
Vaccination rates remained ﬂat last year, and overall the vaccination
completion rates have not passed the 45% mark, even in the general
eligible population (Center for Disease Control P, 2013; Centers or
Disease Control and Prevention, 2012). This evidence increases the
urgency to develop and implement novel and tailored interventions
to increase vaccination rates, to potentially prevent over 60% HPV
related cancer cases in the U.S. In this study we sought to address
the lack of awareness about the vaccine and the reduction in the
rates of adherence after the ﬁrst vaccine dose by educating the
population, and by then providing a reminder system using an
inexpensive modality widely employed by the population, text
messaging. We believe our results are compelling and show that
this approach has the potential to overcome most of the salient vaccine
barriers in the Latino population, increasing the vaccination rate. The
results presented in this pilot study provide strong evidence to support
an effectiveness study, with a rigorous methodology, to assess the effect
of this type of interventions, implemented in community settings, on
HPV vaccination rates.
In a 2013 report, the Centers for Disease Control and Prevention
found that 84% of unvaccinated eligible girls reported a healthcare
encounter where they received a vaccine other than that for HPV
(Center for Disease Control P, 2013). Our study aimed at addressing
this missed opportunity for vaccination by increasing parental
awareness about the vaccine and encouraging parents to ask their
child's provider for the vaccine. Our rates of adherence to the ﬁrst
doses of the vaccine for both groups (above 80% in each group) suggest
that this is a viable intervention, although of short lasting effect. The
addition of text messaging as a reminder system for the second and
third doses seemed to improve the education and awareness effect,
sustaining the vaccination rates through the second and third doses
with a small dropout, although no causality can be assessed in this
pilot study.
We believe our results provide the evidence to support the imple-
mentation of interventions to increase HPV vaccination rates in
non-clinical settings. Community health programs, such as the one
offered at the Mexican Consulate, provide a safe and secure environmentinwhich to disseminate information and implement behavioral interven-
tions. The Mexican Consulate, for example, operates Health Windows in
over ﬁfty consulates across the United States, reaching tens of thousands
of families each year. Other high risk groups have similar trusted commu-
nity structures that can facilitate HPV vaccine education and reminder
systems. Future efforts to increase HPV vaccination rates should target
these settings, particularly among minority and immigrant populations.
Our study has some limitations, themajor one stems from the use of
participant self-report to determine the outcome, although the same
methodology was used across both groups. Another limitation is the
small sample size. Additionally, the lack of random assignment increases
the potential for selection bias. Furthermore, participants in this study
could have been highly motivated to vaccinate their children before
participation in the study, reducing the generalizability of our ﬁndings.
Although our results show the intervention, particularly the text
messaging reminder, as the most signiﬁcant factor associated with
vaccination completion, all participants received frequent calls to
evaluate the outcomes, and this in turn, could be a potential confounder.
Finally, althoughwe found no signiﬁcant statistical differences between
the study populations in each group, some intrinsic differences could
exist and could potentially inﬂuence the ﬁndings.
Conﬂict of interest statement
The authors declare that there are no conﬂicts of interest.
References
Agency for Healthcare Research and Quality, 2011. U.S.-born Mexican women who have
adopted U.S. culture may be more at risk for cervical cancer: research Activities, July
2011, No. 371 Rockville, MD [Cited April 2013]. Available from: http://www.ahrq.
gov/news/newsletters/research-activities/jul11/0711RA31.html.
Allen, Jennifer D., de Jesus, Maria, Mars, Dana, Tom, Laura, Cloutier, Lindsay, Shelton,
Rachel C., 2012. Decision-making about the HPV vaccine among ethnically diverse
parents: implications for health communications. J. Oncol. 2012. http://dx.doi.org/
10.1155/2012/40197 (Article ID 401979, 5 pages).
Center for Disease Control P, 2013. Human papillomavirus vaccination coverage among
adolescent girls, 2007–2012, and postlicensure vaccine safety monitoring,
2006–2013— United States. Morb. Mortal. Wkly Rep. 62 (29), 591–595.
Centers for Disease Control and Prevention: Vaccines for Children Program (VFC), 2013.
Available from: http://www.cdc.gov/vaccines/programs/vfc/index.html (November).
Centers or Disease Control and Prevention, 2012. National and state vaccination coverage
among adolescents aged 13–17 years—United States, 2011 [Cited April 2013]. Available
from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6134a3.htm.
Community Preventive Services Task Force, e. Increasing appropriate vaccination:
community-based interventions implemented in combination Available from: http://
www.thecommunityguide.org/vaccines/RRcommunityinterventions.html.
Fry, R., Passel, J.S., 2009. Latino children: a majority are U.S.-born offspring of immigrants
Available from: http://www.pewhispanic.org/2009/05/28/latino-children-a-majority-
are-us-born-offspring-of-immigrants/ (May).
Guerry, S.L., De Rosa, C.J., Markowitz, L.E., Walker, S., Liddon, N., Kerndt, P.R., Gottlieb, S.L.,
2011. Human papillomavirus vaccine initiation among adolescent girls in high-risk
communities. Vaccine 29 (12), 2235–2241.
Human papillomavirus-associated cancers — United States, 2004–2008. MMWR Morb.
Mortal. Wkly Rep. 61, 258–261.
Jemal, A., Simard, E.P., Dorell, C., Noone, A.M., Markowitz, L.E., Kohler, B., Eheman, C.,
Saraiya, M., Bandi, P., Saslow, D., Cronin, K.A., Watson, M., Schiffman, M., Henley,
S.J., Schymura, M.J., Anderson, R.N., Yankey, D., Edwards, B.K., 2013. Annual Report
to the Nation on the Status of Cancer, 1975–2009, featuring the burden and trends
in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage
levels. J. Natl. Cancer Inst. 105 (3), 175–201.
Kahn, J.A., Lan, D., Kahn, R.S., 2007. Sociodemographic factors associated with high-risk
human papillomavirus infection. Obstet. Gynecol. 110 (1), 87–95.
Kepka, D., Coronado, G., Rodriguez, H., Thompson, B., 2010. Acculturation and HPV infection
among Latinas in the United States. Prev. Med. 51 (2), 182–184.
Kessels, S.J., Marshall, H.S., Watson, M., Braunack-Mayer, A.J., Reuzel, R., Tooher, R.L., 2012.
Factors associated with HPV vaccine uptake in teenage girls: a systematic review.
Vaccine 30 (24), 3546–3556 (May 21).
Kharbanda, E.O., Stockwell, M.S., Fox, H.W., Andres, R., Lara, M., Rickert, V.I., 2011. Text
message reminders to promote human papillomavirus vaccination. Vaccine 29
(14), 2537–2541.
Koutsky, L.A., Ault, K.A., Wheeler, C.M., Brown, D.R., Barr, E., Alvarez, F.B., Chiacchierini,
L.M., Jansen, K.U., 2002. A controlled trial of a human papillomavirus type 16 vaccine.
N. Engl. J. Med. 347 (21), 1645–1651.
Lechuga, J., Vera-Cala, L., Martinez-Donate, A., 2014. HPV vaccine awareness, barriers,
intentions, and uptake in Latina women. J. Immigr. Minor. Health (Nov 29.
[Epub ahead of print]).
558 A. Aragones et al. / Preventive Medicine Reports 2 (2015) 554–558Pew Research Center, 2012. Texting is nearly universal among young adult cell phone
owners Available from: http://www.pewresearch.org/daily-number/texting-is-
nearly-universal-among-young-adult-cell-phone-owners/.
Pew Research Hispanic Center, 2011. The Mexican-American boom: births overtake
immigration Available from: http://www.pewhispanic.org/2011/07/14/the-mexican-
american-boom-brbirths-overtake-immigration/#fn-144-1 (July).
Pew Research Hispanic Center, 2013. A demographic portrait of Mexican-origin Hispanics
in the United States [Cited April 2013]. Available from: http://www.pewhispanic.org/
ﬁles/2013/05/2013-04_Demographic-Portrait-of-Mexicans-in-the-US.pdf.
Podolsky, R., Cremer, M., Atrio, J., Hochman, T., Arslan, A.A., 2009. HPV vaccine acceptability
by Latino parents: a comparison of U.S. and Salvadoran populations. J. Pediatr. Adolesc.
Gynecol. 22 (4), 205–215.
Reiter, P.L., McRee, A.L., Pepper, J.K., Gilkey, M.B., Galbraith, K.V., Brewer, N.T., 2013.
Longitudinal predictors of humanpapillomavirus vaccination among a national sample
of adolescent males. Am. J. Public Health 103 (8), 1419–1427 (Aug 25).U.S. Department of Health and Human Services, 2013. Health people 2020 [Cited April
2013]. Available from: http://www.healthypeople.gov/2020/topicsobjectives2020/
objectiveslist.aspx?topicId=23.
U.S. Food and Drug Administration, 2009. Human papilloma virus vaccine [cited
2013]. Available from: http://www.fda.gov/BiologicsBloodVaccines/Vaccines/
ApprovedProducts/ucm172678.htm.
United States Census Bureau, 2013. 2009–2011 American Community Survey Population
Division — New York City Department of City Planning Available from: http://www.
nyc.gov/html/dcp/html/census/popacs.shtml.
Yeganeh, N., Curtis, D., Kuo, A., 2010. Factors inﬂuencing HPV vaccination status in a
Latino population; and parental attitudes towards vaccine mandates. Vaccine 28
(25), 4186–4191.
